Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Arcus Biosciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered(1) | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||
Fees to be Paid | Equity | Common stock, par value $0.0001 per share | 457(c) | 16,248,095 | $15.49(2) | $251,682,991.55(2) | 0.0001476 | $37,148.41 | ||||||||
| Total Offering Amounts | $251,682,991.55 | $37,148.41 | ||||||||||||||
| Total Fees Previously Paid | — | — | ||||||||||||||
| Total Fee Offsets | — | — | ||||||||||||||
| Net Fees Due | $37,148.41 | |||||||||||||||
| (1) | Represents the shares of common stock, $0.0001 par value per share (the “common stock”), of Arcus Biosciences, Inc. (the “Registrant”) that will be offered for resale by the selling stockholder pursuant to the prospectus to which this exhibit is attached. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares being registered hereunder include such indeterminate number of additional shares of common stock as may be issuable as a result of stock splits, stock dividends or similar transactions with respect to the shares being registered hereunder. |
| (2) | This estimate is made pursuant to Rule 457(c) and (h) of the Securities Act solely for purposes of calculating the registration fee. The price per share and aggregate offering price are based upon the average of the high and low prices of the Registrant’s common stock on February 13, 2024, as reported on the New York Stock Exchange. |
